v3.26.3
The Company and Basis of Presentation (Tables)
12 Months Ended
Jun. 30, 2026
The Company and Basis of Presentation [Abstract]  
Schedule of Company’s Entity Structure at the End of the Reporting Period

Details of the Company’s entity structure at the end of the reporting period are as follows:

Name

 

Entity

 

Country of Incorporation

Neuphoria Therapeutics, Inc.

 

Parent

 

United States

Bionomics Limited

 

Subsidiary

 

Australia

Bionomics, Inc.

 

Subsidiary

 

United States